A database of FDA approved therapeutic peptides and proteins
ID1844 | ThPPIDTh1232 | NameLenograstim | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseImmunological Disorders | BrandGranocyte | CompanyNA | Physical AppearanceSolid | Route of AdministartionSubcutaneous or Intravenous | CategoryAntineoplastic and Immunomodulating Agents | TargetGranulocyte colony-stimulating factor receptor |
ID1845 | ThPPIDTh1233 | NamePegloticase | Peptide SequenceTYKKNDEVEFVRTGYGKDMI Full view | Length298 | Functional ClassificationIb | DiseaseOsteological Disorders | BrandPegloticase (Krystexxa) | CompanyNA | Physical AppearanceSolid | Route of AdministartionIntravenous | CategoryEnzymes | TargetUric acid |
ID1846 | ThPPIDTh1234 | NameProtamine sulfate | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandProtamine Sulfate Injection, USP | CompanyOmega Laboratories Ltd | Physical Appearanceoff-white amorphous or crystalline powder | Route of AdministartionIntravenous | CategoryHeparin Antagonists, Hematologic Agents | TargetNA |
ID1847 | ThPPIDTh1235 | NameProtein S human | Peptide SequenceANSLLEETKQGNLERECIEE Full view | Length635 | Functional ClassificationIb | DiseaseMetabolic Disorders | BrandProtein S human | CompanyNA | Physical Appearance Solid | Route of AdministartionNA | CategoryAnticoagulant plasma protein | TargetNA |
ID1849 | ThPPIDTh1237 | NameSomatropin recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIb | DiseaseHormonal Disorders | BrandBioTropin | CompanyBiotech General | Physical AppearancePowder and Solvent for Solution | Route of AdministartionSubcutaneous | CategoryHormones, Hormone Substitutes, and Hormone Antagonists | TargetGrowth hormone receptor, Prolactin receptor |
ID1850 | ThPPIDTh1237 | NameSomatropin recombinant | Peptide SequenceFPTIPLSRLFDNAMLRAHRL Full view | Length191 | Functional ClassificationIb | DiseaseHormonal Disorders | BrandNutropinAQ | CompanyGenentech Inc. | Physical AppearanceSterile liquid | Route of AdministartionSubcutaneous | CategoryHormones, Hormone Substitutes, and Hormone Antagonists | TargetGrowth hormone receptor, Prolactin receptor |
ID1851 | ThPPIDTh1238 | NameSusoctocog alfa | Peptide SequenceAIRRYYLGAVELSWDYRQSE Full view | Length1448 | Functional ClassificationIb | DiseaseHematological Disorders | BrandObizur | CompanyNA | Physical AppearancePowder and solvent for solution for injection. | Route of AdministartionIntravenous | CategoryBlood coagulation factors, Antihaemorrhagics | Targetvon Willebrand factor |
ID1852 | ThPPIDTh1239 | NameThrombomodulin Alfa | Peptide SequenceNA Full view | Length0 | Functional ClassificationIb | DiseaseHematological Disorders | BrandRecomodulin (in Japan only) | CompanyAsahi Kasei Pharma Corp | Physical Appearancelyophilized powder for solution | Route of AdministartionIntravenous | CategoryAnticoagulant agent, Antiplatelet agent | TargetProthrombin, Coagulation factor V |